MyFinsight
Home
About
Contact
tars: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, TARS has $534,561K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
534,561
494,994
Total stockholders equity
335,082
332,612
Total liabilities and stockholders equity
534,561
494,994
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Buy me a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses
$21,695K
Other receivables
$1,716K
Inventory
$3,836K
Accounts receivable, net
$72,620K
Marketable securities
$289,113K
Cash and cash
equivalents
$112,724K
Other assets
$1,177K
Long-term investments
$3,000K
Operating lease
right-of-use assets
$10,233K
Intangible assets, net
$7,606K
Property and equipment,
net
$5,746K
Inventory, non-current
$2,532K
Restricted cash,
non-current
$2,563K
Total current assets
$501,704K
Total assets
$534,561K
Total liabilities and
stockholders equity
$534,561K
Total stockholders
equity
$335,082K
Total liabilities
$199,479K
Accumulated deficit
-$418,255K
Accumulated other
comprehensive income (loss)
$289K
Additional paid-in capital
$753,042K
Other long-term
liabilities
$10,148K
Long-term debt, net
$72,281K
Total current
liabilities
$117,050K
Common stock, 0.0001
par value...
$6K
Accrued payroll and
benefits
$13,552K
Accounts payable and
other accrued...
$103,498K
Subscribe for Financial Insights
Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS)